Elliot G Arsoniadis1,2, Yen-Yi Ho3, Genevieve B Melton2,4, Robert D Madoff4, Chap Le3, Mary R Kwaan4. 1. Department of Surgery, University of Minnesota, Minneapolis, Minnesota, USA. 2. Institute for Health Informatics, University of Minnesota, Minneapolis, Minnesota, USA. 3. Division of Biostatistics, School of Public Health, University of Minnesota, Minneapolis, Minnesota, USA. 4. Division of Colon & Rectal Surgery, Department of Surgery, University of Minnesota, Minneapolis, Minnesota, USA.
Abstract
BACKGROUND: Previous reports on racial disparities in the treatment of Crohn's disease [CD] in African American [AA] patients have shown differences in both medical and surgical treatments in this population. No study thus far has examined the effect of AA race on outcomes after surgery for CD. METHODS: Utilizing the National Surgical Quality Improvement Program [NSQIP] Participant User File [PUF] for the years 2005-2013, we examined the effect of AA race on postoperative complications in patients with CD undergoing intestinal surgery. RESULTS: AA patients had a significantly higher rate of complications overall compared to non-AA patients [23.5% vs 18.9%, p = 0.002]. Postoperative sepsis [10.9% vs 6.6%, p < 0.001] and surgical site infection [17.6% vs 14.8%, p = 0.037] were most significant. After adjustment for age, sex, preoperative disease severity and lifestyle factors [smoking], race remained a statistically significant factor in postoperative complication rate. Only after additional adjustment was made for comorbidities and American Society of Anesthesiologists class did race lose significance within our model. CONCLUSION: African Americans experience a greater amount of postoperative complications following surgery for Crohn's disease. Preoperative disease management, addressing smoking status and control of comorbid disease are important factors in addressing the racial disparities in the surgical treatment of Crohn's disease.
BACKGROUND: Previous reports on racial disparities in the treatment of Crohn's disease [CD] in African American [AA] patients have shown differences in both medical and surgical treatments in this population. No study thus far has examined the effect of AA race on outcomes after surgery for CD. METHODS: Utilizing the National Surgical Quality Improvement Program [NSQIP] Participant User File [PUF] for the years 2005-2013, we examined the effect of AA race on postoperative complications in patients with CD undergoing intestinal surgery. RESULTS: AA patients had a significantly higher rate of complications overall compared to non-AA patients [23.5% vs 18.9%, p = 0.002]. Postoperative sepsis [10.9% vs 6.6%, p < 0.001] and surgical site infection [17.6% vs 14.8%, p = 0.037] were most significant. After adjustment for age, sex, preoperative disease severity and lifestyle factors [smoking], race remained a statistically significant factor in postoperative complication rate. Only after additional adjustment was made for comorbidities and American Society of Anesthesiologists class did race lose significance within our model. CONCLUSION: African Americans experience a greater amount of postoperative complications following surgery for Crohn's disease. Preoperative disease management, addressing smoking status and control of comorbid disease are important factors in addressing the racial disparities in the surgical treatment of Crohn's disease.
Authors: Karim Alavi; J A Cervera-Servin; Paul R Sturrock; W B Sweeney; Justin A Maykel Journal: J Gastrointest Surg Date: 2011-11-29 Impact factor: 3.452
Authors: Suhal S Mahid; Aaron M Mulhall; Ryan D Gholson; M Robert Eichenberger; Susan Galandiuk Journal: Inflamm Bowel Dis Date: 2008-07 Impact factor: 5.325
Authors: Rocco Ricciardi; Beth A Virnig; Robert D Madoff; David A Rothenberger; Nancy N Baxter Journal: Dis Colon Rectum Date: 2007-08 Impact factor: 4.585
Authors: Adjoa Anyane-Yeboa; Akihiro Yamada; Haider Haider; Yunwei Wang; Yuga Komaki; Fukiko Komaki; Joel Pekow; Sushila Dalal; Russell D Cohen; Lisa Cannon; Konstantin Umanskiy; Radhika Smith; Roger Hurst; Neil Hyman; David T Rubin; Atsushi Sakuraba Journal: Aliment Pharmacol Ther Date: 2018-08-20 Impact factor: 8.171